ARCHIVES

Robert Day Named New Director At Hutchinson Center

This article is from The Cancer Letter archive.

Vol. 07 No. 25 | June 19, 1981

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

Upton Says He’s Still Undecided About Leaving NCI

September 28, 1979

Clinical Trials Approved By NCI CTEP Last Month

March 25, 2011

ODAC To Advise FDA on First Biosimilars Application Jan. 7

December 19, 2014

In Brief: San Antonia Cancer Institute Designated Comprehensive; Yeast DNA Described

May 3, 1996

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

April 20, 2012